Sustained immune tolerance induction in enzyme replacement therapy–treated CRIM-negative patients with infantile Pompe diseaseZoheb B. Kazi, Priya S. Kishnani, Eli Herskovitz et al.|JCI Insight|2017Cited by 72
An immune tolerance approach using transient low-dose methotrexate in the ERT-naïve setting of patients treated with a therapeutic protein: experience in infantile-onset Pompe diseaseZoheb B. Kazi, Priya S. Kishnani, Ankit K. Desai et al.|Genetics in Medicine|2018Cited by 34
Prophylactic immune modulation in infantile Ρompe disease using low-dose methotrexate induction: A safe, inexpensive, widely accessible, and efficacious strategyZoheb B. Kazi, Priya S. Kishnani, Ankit K. Desai et al.|Molecular Genetics and Metabolism|2016Cited by 4
An immune tolerance approach using methotrexate in the naïve setting of patients treated with a therapeutic protein: Experience in infantile Pompe diseaseAnkit K. Desai, Priya S. Kishnani, Zoheb B. Kazi et al.|Molecular Genetics and Metabolism|2018Cited by 1